🔎 Trials Near Me

Gara Jalqabaatti › Myelodysplastic Syndromes › Ohio › Cleveland

Qorannoo klinikaalii Myelodysplastic Syndromes Cleveland, OH keessatti

Qorannoo 11 Myelodysplastic Syndromes f Cleveland fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Case Western Reserve University, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • Cleveland Clinic, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Namoota walitti qabaa jiraSadarkaa 3
  • Cleveland clinic OH, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07422480

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

Namoota walitti qabaa jiraSadarkaa 2
  • Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06904482

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT03471260

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Namoota walitti qabaa jiraSadarkaa 3
  • Cleveland Clinic - Cleveland, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT06499285

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Cleveland Clinic, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT05308264

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

Namoota walitti qabaa jiraSadarkaa jalqabaa 1
  • Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT04187703

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

Namoota walitti qabaa jiraSadarkaa 1
  • Cleveland Clinic Cancer Center, Cleveland
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Bit-2026 · NCT06543381

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Mayfield Heights · Miili 12 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Myelodysplastic Syndromes magaalota biroo keessatti

Qorannoo biroo Cleveland keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.